Skip to main content

Table 2 Comparison of Main Demographics and Health History Between BZD Users and Non-Users in the Methadone programs

From: Benzodiazepine Use and Misuse Among Patients in a Methadone Program

Variables

Non-Users

(n ≤ 101)

BZN-Users

(n ≤ 90)

p ≤ a

Demographics

   

   % female

40.4%

48.1%

.442

   Mean age (SD)

47.5 (7.1)

45.4 (10.3)

.107

   % of White/Caucasian

11.1%

35.3%

.001

   % of Single (never married)

53.5%

42.7%

.369

   Religiosity (1--10 scale)

7.12 (1.9)

6.17 (2.3)

.003

Health Issues

   

General Health Status

   

➤ Poor

➤ Ok, but below average

➤ Fair

➤ Good

➤ Excellent

7.1

11.1

33.3

45.5

3.0

1.1

26.1

37.5

31.8

3.4

.017

   % had chronic medical problems

36.7%

47.5%

.153

   % ever had prescribed med for mental Or emotional problems

21.6%

40.0%

.007

   % have had anxiety or sleeping problems before starting use of opiates/heroin

36.8%

61.2%

.005

   % have had anxiety or sleeping problems before entering methadone program

48.4%

78.3%

.001

   Age of onset into alcohol use

16.5 (6.5)

14.9 (4.6)

.073

   Age of onset into opiate/heroin use

23.5 (7.7)

21.7 (7.5)

.120

   Age first admitted to a methadone program

37.1 (15.3)

35.3 (11.3)

.387

   # of days with mental or emotional problems In the past 30 days

6.28 (9.9)

10.4 (11.6)

.048

Psychological Measurements

   

   Anxiety sensitivity - physical score

7.94 (6.1)

8.96 (5.4)

.231

   Anxiety sensitivity - cognitive score

4.68 (5.4)

6.54 (5.4)

.020

   Anxiety sensitivity - social score

5.78 (5.2)

6.98 (5.1)

.115

   Anxiety sensitivity - Total score

18.4 (15.1)

22.4 (13.7)

.058

   Perceived Stress Scale

15.6 (8.2)

18.6 (7.4)

.011

   CES Depression scale

37.8 (10.4)

42.7 (8.5)

.001

   Spielberg Anxiety State score

40.9 (11.6)

44.4 (10.6)

.036

  1. a. P values are from chi-square test for categorical variables in contingency table, and F test continuous variables in ANOVA.